ClinicalTrials.Veeva

Menu

Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device

Seoul National University logo

Seoul National University

Status

Enrolling

Conditions

Hypertension
Prehypertension
Diastolic Hypertension
Systolic Hypertension
Essential Hypertension
Obstructive Sleep Apnea
Blood Pressure

Treatments

Device: CART-I Plus

Study type

Interventional

Funder types

Other

Identifiers

NCT06084065
2305-064-1431

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the feasibility and effectiveness of a ring-type blood pressure measurement device compared to a 24-hour ambulatory blood pressure monitoring device in patients with hypertension or suspected hypertension. The main question it aims to answer is whether the 24-hour blood pressure measurement accuracy of the ring-type blood pressure monitor is similar to that of the 24-hour ambulatory blood pressure monitor. To participate, subjects must wear a ring blood pressure monitor and an ambulatory blood pressure monitor simultaneously for 24 hours.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients scheduled for 24-hour ambulatory blood pressure monitoring for diagnostic purposes among those suspected of having hypertension

  2. Confirmed hypertensive patients scheduled for 24-hour ambulatory blood pressure monitoring for treatment purposes

    • Either criterion 1 or 2 are planned to be selected as study participants.

Exclusion criteria

  • Participants who do not consent to the study
  • Individuals with a Body Mass Index of 30 or above (there's a concern of measurement errors as the standard 24-hour ambulatory blood pressure cuffs may not fit well)
  • Pregnancy
  • Baseline heart disease patients: individuals with a history of hospitalization due to heart failure, valvular disease, or myocardial infarction
  • Patients diagnosed with atrial fibrillation on a 12 lead EKG within the past 6 months
  • End-stage renal disease (patients undergoing dialysis)
  • Users of mobile phones that are not compatible with the test device (CART-I plus) used in the study

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Ring arm
Experimental group
Treatment:
Device: CART-I Plus

Trial contacts and locations

1

Loading...

Central trial contact

Hae-Young Lee, Professor; Huijin Lee, Clinical Fellow

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems